Skip to Content

Medications for Positron Emission Tomography Imaging

Other names: PET Imaging

What is Positron Emission Tomography Imaging: Positron emission tomography (PET) is a nuclear medicine imaging technique that produces a three-dimensional image or picture of functional processes in the body.

Compare drugs associated with Positron Emission Tomography Imaging

The following list of medications are in some way related to, or used in the treatment of this condition.

Drug name Rx / OTC Pregnancy CSA Alcohol Reviews Rating Popularity
Neuraceq Rx C N Add review Add

Generic name: florbetaben f-18 systemic

Drug class: diagnostic radiopharmaceuticals

For consumers: dosage, side effects

For professionals: Prescribing Information

 
Vizamyl Rx C N Add review Add

Generic name: flutemetamol f-18 systemic

Drug class: diagnostic radiopharmaceuticals

For consumers: dosage, side effects

For professionals: Prescribing Information

 
Amyvid Rx C N Add review Add

Generic name: florbetapir F 18 systemic

Drug class: diagnostic radiopharmaceuticals

For consumers: dosage, side effects

For professionals: Prescribing Information

 
florbetapir F 18 Rx C N Add review Add

Generic name: florbetapir F 18 systemic

Brand name:  Amyvid

Drug class: diagnostic radiopharmaceuticals

For consumers: dosage, side effects

 
flutemetamol f-18 Rx C N Add review Add

Generic name: flutemetamol f-18 systemic

Brand name:  Vizamyl

Drug class: diagnostic radiopharmaceuticals

For consumers: side effects

 
Axumin Rx U Add review Add

Generic name: fluciclovine F 18 systemic

Drug class: diagnostic radiopharmaceuticals

For consumers: dosage, side effects

For professionals: Prescribing Information

 
fluciclovine F 18 Rx U Add review Add

Generic name: fluciclovine F 18 systemic

Brand name:  Axumin

Drug class: diagnostic radiopharmaceuticals

For consumers: side effects

 
Cardiogen-82 Rx C N Add review Add

Generic name: rubidium chloride rb-82 systemic

Drug class: diagnostic radiopharmaceuticals

For consumers: dosage, side effects

For professionals: Prescribing Information

 
gallium ga 68 dotatate Rx U Add review Add

Generic name: gallium ga 68 dotatate systemic

Brand name:  Netspot

Drug class: radiologic conjugating agents

For consumers: interactions, side effects

 
Netspot Rx U Add review Add

Generic name: gallium ga 68 dotatate systemic

Drug class: radiologic conjugating agents

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

 
rubidium chloride rb-82 Rx C N Add review Add

Generic name: rubidium chloride rb-82 systemic

Brand names:  Cardiogen-82, Ruby-Fill

Drug class: diagnostic radiopharmaceuticals

For consumers: side effects

 
Ruby-Fill Rx C N Add review Add

Generic name: rubidium chloride rb-82 systemic

Drug class: diagnostic radiopharmaceuticals

For consumers: dosage, side effects

For professionals: Prescribing Information

 
florbetaben f-18 Rx C N Add review Add

Generic name: florbetaben f-18 systemic

Brand name:  Neuraceq

Drug class: diagnostic radiopharmaceuticals

For consumers: side effects

 

Legend

Off Label This medication may not be approved by the FDA for the treatment of this condition.
Prescription Only / Over the Counter
Rx Prescription Only
OTC Over the Counter
Rx/OTC Prescription or Over the Counter
Pregnancy
A Adequate and well-controlled studies have failed to demonstrate a risk to the fetus in the first trimester of pregnancy (and there is no evidence of risk in later trimesters).
B Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.
C Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use in pregnant women despite potential risks.
D There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use in pregnant women despite potential risks.
X Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use in pregnant women clearly outweigh potential benefits.
N FDA has not classified the drug.
Controlled Substances Act Schedule
N Is not subject to the Controlled Substances Act.
1 Has a high potential for abuse. Has no currently accepted medical use in treatment in the United States. There is a lack of accepted safety for use under medical supervision.
2 Has a high potential for abuse. Has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse may lead to severe psychological or physical dependence.
3 Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence.
4 Has a low potential for abuse relative to those in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3.
5 Has a low potential for abuse relative to those in schedule 4. Has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 4.
Alcohol
X Interacts with Alcohol.

Browse Drugs by Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Hide